The threat caused by the SARS-CoV-2 virus is a global one. Therefore, we have to address the coronavirus...
COVID-19
First emergency approvals of vaccines and antibody drugs in less than a year are great achievements of modern...
While media reports suggest AstraZeneca’s COVID-19 jab might have caused blot clots, the EMA didn't confirm a...
Swiss Roche AG has missed the primary endpoint in the REMDACTA trial in patients with severe COVID-19...
As rapidly spreading mutants of SARS-CoV-2 are emerging, two Tuebingen-based vaccine developers will develop...
J&J subsidiary Janssen Pharma has presented updated Phase I/II antibody levels supporting a single shot...
German Researchers have unraveled how remdesivir interferes with the viral RNA polymerase and why it does not...
Share
